Roche’s Cancer Drug Patent Partly Revoked in India

by Kathy Jones on  August 5, 2013 at 8:20 PM Drug News
RSS Email Print This Page Comment
Swiss drugmaker Roche confirmed that the Indian government has partly revoked the patents granted for its breast cancer drug Herceptin.
 Roche’s Cancer Drug Patent Partly Revoked in India
Roche’s Cancer Drug Patent Partly Revoked in India
Advertisement

A company spokesperson it has received notification from the Kolkata Patent Office on July 17 that it has lifted divisional patents for Herceptin as they were not properly submitted.

Advertisement
The announcement comes just a few days after India revoked GlaxoSmithKline's patent for its breast cancer drug Tykerb.

"I can confirm that the Assistant Controller of Patents at the Kolkata Patent Office has revoked divisional patents of Herceptin and that we are now considering the further course of action", a spokesman for Roche said.


Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Oncology Drug Delivery Systems Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive